SEB Asset Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$17.6M Sell
293,461
-118,689
-29% -$7.47M 0.07% 237
2026
Q2
$23.6M Buy
412,150
+118,873
+41% +$6.51M 0.09% 196
2026
Q1
$16.6M Buy
+293,277
New +$17.1M 0.07% 230

Other funds holding BMRN

SEB Asset Management's BMRN Position: Q3 2026 in Review

SEB Asset Management reduced its BioMarin Pharmaceuticals (BMRN) stake by 29% in Q3 2026, selling an estimated $7.47M and leaving 293,461 shares worth $17.6M. The position accounts for 0.07% of the portfolio, ranked #237.

SEB Asset Management first reported a position in BMRN in Q1 2026 and has held it in 3 quarters since. The position peaked at $23.6M in Q2 2026. 567 funds tracked by Wall St. Rank hold BMRN as of Q3 2026.

  • SEB Asset Management held 293,461 shares of BioMarin Pharmaceuticals worth $17.6M as of Q3 2026.
  • SEB Asset Management sold 118,689 BioMarin Pharmaceuticals shares in Q3 2026, an estimated $7.47M.
  • BioMarin Pharmaceuticals made up 0.07% of SEB Asset Management's portfolio in Q3 2026, its #237 holding.
  • SEB Asset Management first reported a position in BioMarin Pharmaceuticals in Q1 2026 and has held it in 3 quarters since.
  • SEB Asset Management's BioMarin Pharmaceuticals position peaked at $23.6M in Q2 2026.
  • 567 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q3 2026.

Based on SEB Asset Management's 13F filing for Q3 2026, filed 4 Nov 2026.